Skip to main content
. 2021 Dec 6;9:681665. doi: 10.3389/fcell.2021.681665

FIGURE 5.

FIGURE 5

Human embryonic stem cell (hES2)-derived human ventricular cardiac anisotropic sheet (hvCAS) paced at 1.5 Hz during acute hypokalaemic (hypoK) experiment where the treatment was for 15 min before data acquisition. Number of samples is represented by n where the first number refers to control (5 mM KCl in Tyrode solution) samples and the second number refers to hypoK (3 mM KCl in Tyrode solution) samples. (A) Action Potential (AP) Longitudinal Conduction Velocity (LCV) (n = 9, 7)and Transverse Conduction Velocity (TCV) (n = 12, 11). The velocity was measured by calculating the speed of AP propagation from one point to the other. (B) AP Anisotropic Ratio (AR) which is the ratio of LCV to TCV. (n = 9, 8). (C) AP Effective Refractory Period (ERP). (n = 12, 13) Conduction Velocity decreased in hypokalaemic condition (asterisk, p < 0.05 for both LCV and TCV). ERP of hvCAS paced at 1.5 Hz (8 trains) followed by an extra premature stimulus which was gradually shortened to find ERP was decreased in hypokalaemic condition (asterisk, p < 0.001). AR is between 1.4 and 1.8, resembling more closer to the native human ventricle (AR = 3) in normokalaemia as well as in hypokalaemia.